Management of type 2 diabetes in patients with heart failure (Q40025916)

16 September 2017

Management of type 2 diabetes in patients with heart failure (English)

1 reference

16 September 2017

1 reference

David Aguilar

1

1 reference

16 September 2017

1 December 2008

1 reference

Current treatment options in cardiovascular medicine

16 September 2017

1 reference

16 September 2017

10

1 reference

16 September 2017

6

1 reference

16 September 2017

465-475

1 reference

https://scigraph.springernature.com/pub.10.1007/s11936-008-0039-4

16 September 2017

0 references

cites work

Glycemic control and heart failure among adult patients with diabetes

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11936-008-0039-4

Association of poor glycemic control with prolonged hospital stay in patients with diabetes admitted with exacerbation of congestive heart failure

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11936-008-0039-4

Diabetic cardiomyopathy revisited

21 January 2018

1 reference

12 December 2020

Lactic acidosis in patients with diabetes treated with metformin

1 reference

12 December 2020

Effect of various diuretic treatments on rosiglitazone-induced fluid retention.

1 reference

12 December 2020

Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention

1 reference

12 December 2020

Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure

1 reference

12 December 2020

Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes

1 reference

12 December 2020

Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited

1 reference

12 December 2020

The phantom of lactic acidosis due to metformin in patients with diabetes

1 reference

12 December 2020

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

1 reference

12 December 2020

Improved clinical outcomes associated with metformin in patients with diabetes and heart failure

1 reference

12 December 2020

Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institut

1 reference

12 December 2020

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

1 reference

12 December 2020

Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?

1 reference

12 December 2020

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

1 reference

12 December 2020

Effects of intensive glucose lowering in type 2 diabetes

1 reference

12 December 2020

Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption

1 reference

12 December 2020

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials

1 reference

12 December 2020

Pioglitazone and heart failure: results from a controlled study in patients with type 2 diabetes mellitus and systolic dysfunction

1 reference

12 December 2020

The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure

1 reference

12 December 2020

The incidence of congestive heart failure in type 2 diabetes: an update

1 reference

12 December 2020

A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.

1 reference

12 December 2020

Heart Failure Prevalence, Incidence, and Mortality in the Elderly With Diabetes

1 reference

12 December 2020

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials

1 reference

12 December 2020

Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state

1 reference

12 December 2020

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

12 December 2020

Metformin in heart failure

1 reference

12 December 2020

Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy

1 reference

12 December 2020

Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

Exenatide: a new option for the treatment of type 2 diabetes

1 reference

12 December 2020

Therapeutic roles of peroxisome proliferator-activated receptor agonists

1 reference

12 December 2020

Diabetic retinopathy and risk of heart failure

1 reference

12 December 2020

Diabetes, left ventricular systolic dysfunction, and chronic heart failure

1 reference

12 December 2020

Phenformin-associated lactic acidosis: pathogenesis and treatment

1 reference

12 December 2020

Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study

1 reference

12 December 2020

In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control

1 reference

12 December 2020

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

1 reference

12 December 2020

The incidence of congestive heart failure associated with antidiabetic therapies

1 reference

12 December 2020

Diabetes and cardiovascular disease. The Framingham study

1 reference

12 December 2020

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

12 December 2020

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

12 December 2020

Diabetes in heart failure: prevalence and impact on outcome in the population

1 reference

12 December 2020

The association of heart failure with insulin resistance and the development of type 2 diabetes

1 reference

12 December 2020

Effect of glucagon-like peptide 1 on non-insulin-mediated glucose uptake in the elderly patient with diabetes

1 reference

12 December 2020

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

1 reference

12 December 2020

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

1 reference

12 December 2020

Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction

1 reference

12 December 2020

Predictors of mortality and morbidity in patients with chronic heart failure

1 reference

12 December 2020

10.1007/S11936-008-0039-4

Identifiers

DOI

1 reference

PubMed ID

19026177

Dimensions Publication ID

16 September 2017

1047399994

0 references

Fatcat ID

release_k2ulootci5b4jfm2ifl4ghaciy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k2ulootci5b4jfm2ifl4ghaciy

24 November 2022

mapped directly with Wikidata item

PubMed ID

19026177

1 reference

PubMed ID

19026177